FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2099668830> ?p ?o ?g. }

• W2099668830 endingPage "520" @default.
• W2099668830 startingPage "515" @default.
• W2099668830 abstract "Objective: Neointimal hyperplasia is the first step in a cascade leading to a reduced patency rate of saphenous vein grafts in comparison to arterial grafts in coronary artery bypass grafting. Using cultured human saphenous vein grafts as a model for coronary artery bypass grafting, we investigated if the mammalian target of rapamycin inhibitor everolimus attenuates neointimal hyperplasia. Methods: Saphenous vein grafts from 10 patients undergoing coronary artery bypass grafting were processed as follows: from each patient, one segment served as baseline control at day 0. Two segments were cultured in a neointimal hyperplasia model separately. One received no treatment and the other everolimus (1 μM). All vein grafts underwent histomorphometric analysis, assessment of proliferation by Ki-67 immunostaining and quantification of phospho-S6 ribosomal protein using western blot analysis. Results: Everolimus treatment resulted in reduced neointimal hyperplasia (thickness 3.7 ± 1.2 μm) compared to untreated controls (10.1 ± 2.5 μm, p = 0.008). The intima/intima + media-ratio was reduced in the everolimus group (0.10 ± 0.02) compared to untreated controls (0.24 ± 0.07, p = 0.008). The number of Ki-67 positive proliferating cells in everolimus treated vein grafts (15 ± 7 cells/high power field) showed a tendency of reduction compared to untreated controls (36 ± 20 cells/high power field, p = 0.036). Finally, everolimus treatment resulted in downregulation of S6 ribosomal protein phosphorylation in comparison to untreated controls. Conclusion: Everolimus is able to reduce neointimal proliferation in cultured human saphenous vein grafts by inhibition of the mammalian target of rapamycin, even though different transfection methods are to be evaluated for a clinical application in coronary artery bypass grafting." @default.
• W2099668830 created "2016-06-24" @default.
• W2099668830 creator A5007410452 @default.
• W2099668830 creator A5008315598 @default.
• W2099668830 creator A5026877165 @default.
• W2099668830 creator A5027964978 @default.
• W2099668830 creator A5041840008 @default.
• W2099668830 creator A5042595072 @default.
• W2099668830 creator A5078175474 @default.
• W2099668830 creator A5080868201 @default.
• W2099668830 date "2009-03-01" @default.
• W2099668830 modified "2023-10-02" @default.
• W2099668830 title "Everolimus attenuates neointimal hyperplasia in cultured human saphenous vein grafts☆" @default.
• W2099668830 cites W1968460690 @default.
• W2099668830 cites W1971680920 @default.
• W2099668830 cites W1982130940 @default.
• W2099668830 cites W1985046929 @default.
• W2099668830 cites W2000825997 @default.
• W2099668830 cites W2004349592 @default.
• W2099668830 cites W2022050378 @default.
• W2099668830 cites W2028549543 @default.
• W2099668830 cites W2035258932 @default.
• W2099668830 cites W2039207650 @default.
• W2099668830 cites W2043563089 @default.
• W2099668830 cites W2045757667 @default.
• W2099668830 cites W2060100969 @default.
• W2099668830 cites W2078043377 @default.
• W2099668830 cites W2079315105 @default.
• W2099668830 cites W2080471069 @default.
• W2099668830 cites W2081397252 @default.
• W2099668830 cites W2110762577 @default.
• W2099668830 cites W2148993124 @default.
• W2099668830 cites W2154555522 @default.
• W2099668830 cites W2160563474 @default.
• W2099668830 cites W2517054293 @default.
• W2099668830 doi "https://doi.org/10.1016/j.ejcts.2008.11.035" @default.
• W2099668830 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19167904" @default.
• W2099668830 hasPublicationYear "2009" @default.
• W2099668830 type Work @default.
• W2099668830 sameAs 2099668830 @default.
• W2099668830 citedByCount "8" @default.
• W2099668830 countsByYear W20996688302012 @default.
• W2099668830 countsByYear W20996688302014 @default.
• W2099668830 countsByYear W20996688302016 @default.
• W2099668830 countsByYear W20996688302019 @default.
• W2099668830 countsByYear W20996688302023 @default.
• W2099668830 crossrefType "journal-article" @default.
• W2099668830 hasAuthorship W2099668830A5007410452 @default.
• W2099668830 hasAuthorship W2099668830A5008315598 @default.
• W2099668830 hasAuthorship W2099668830A5026877165 @default.
• W2099668830 hasAuthorship W2099668830A5027964978 @default.
• W2099668830 hasAuthorship W2099668830A5041840008 @default.
• W2099668830 hasAuthorship W2099668830A5042595072 @default.
• W2099668830 hasAuthorship W2099668830A5078175474 @default.
• W2099668830 hasAuthorship W2099668830A5080868201 @default.
• W2099668830 hasBestOaLocation W20996688301 @default.
• W2099668830 hasConcept C126322002 @default.
• W2099668830 hasConcept C126894567 @default.
• W2099668830 hasConcept C141071460 @default.
• W2099668830 hasConcept C164705383 @default.
• W2099668830 hasConcept C2776820930 @default.
• W2099668830 hasConcept C2777202286 @default.
• W2099668830 hasConcept C2777339539 @default.
• W2099668830 hasConcept C2777562237 @default.
• W2099668830 hasConcept C2778095995 @default.
• W2099668830 hasConcept C2778283817 @default.
• W2099668830 hasConcept C2778583881 @default.
• W2099668830 hasConcept C2779699572 @default.
• W2099668830 hasConcept C2779751240 @default.
• W2099668830 hasConcept C2992686903 @default.
• W2099668830 hasConcept C71924100 @default.
• W2099668830 hasConceptScore W2099668830C126322002 @default.
• W2099668830 hasConceptScore W2099668830C126894567 @default.
• W2099668830 hasConceptScore W2099668830C141071460 @default.
• W2099668830 hasConceptScore W2099668830C164705383 @default.
• W2099668830 hasConceptScore W2099668830C2776820930 @default.
• W2099668830 hasConceptScore W2099668830C2777202286 @default.
• W2099668830 hasConceptScore W2099668830C2777339539 @default.
• W2099668830 hasConceptScore W2099668830C2777562237 @default.
• W2099668830 hasConceptScore W2099668830C2778095995 @default.
• W2099668830 hasConceptScore W2099668830C2778283817 @default.
• W2099668830 hasConceptScore W2099668830C2778583881 @default.
• W2099668830 hasConceptScore W2099668830C2779699572 @default.
• W2099668830 hasConceptScore W2099668830C2779751240 @default.
• W2099668830 hasConceptScore W2099668830C2992686903 @default.
• W2099668830 hasConceptScore W2099668830C71924100 @default.
• W2099668830 hasIssue "3" @default.
• W2099668830 hasLocation W20996688301 @default.
• W2099668830 hasLocation W20996688302 @default.
• W2099668830 hasOpenAccess W2099668830 @default.
• W2099668830 hasPrimaryLocation W20996688301 @default.
• W2099668830 hasRelatedWork W2007569401 @default.
• W2099668830 hasRelatedWork W2044911506 @default.
• W2099668830 hasRelatedWork W2046812018 @default.
• W2099668830 hasRelatedWork W2090205488 @default.
• W2099668830 hasRelatedWork W2091350451 @default.
• W2099668830 hasRelatedWork W2165230742 @default.
• W2099668830 hasRelatedWork W2358320353 @default.

• next